SOFTMEDX(00648) offers a 96% discount on the issuance of approximately 16.30 million planned shares.

(00648) announced that due to its continuous deteriorating financial situation since the suspension of trading, the company has decided to undergo debt restructuring through a plan in 2023. In December 2023, the plan was registered at the company registry office and has become effective. To complete the plan, the company is required to issue 16,301,841 planned shares to creditors at an issue price of HK$0.01 per share within six months from the date of resumption of trading, representing a 96% discount from the closing price of HK$0.28 per share reported on the Stock Exchange at the date of this announcement.